(Q41688195)

7 October 2017

title

High APOBEC3B expression is a predictor of recurrence in patients with low-risk clear cell renal cell carcinoma (English)

1 reference

7 October 2017

Le Xu

1

1 reference

7 October 2017

Yuan Chang

2

1 reference

7 October 2017

Huimin An

3

1 reference

7 October 2017

Yu Zhu

4

1 reference

7 October 2017

Yuanfeng Yang

5

1 reference

7 October 2017

Jiejie Xu

6

1 reference

7 October 2017

publication date

4 June 2015

1 reference

7 October 2017

1 reference

7 October 2017

volume

33

1 reference

7 October 2017

issue

8

1 reference

7 October 2017

page(s)

340.e1-8

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.009

7 October 2017

1 reference

Systematic review of oncological outcomes following surgical management of localised renal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.009

Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.009

Prognostic factors and predictive models in renal cell carcinoma: a contemporary review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.009

Improved prognostication of renal cell carcinoma using an integrated staging system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.009

Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.009

Signatures of mutational processes in human cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.009

APOBEC3B is an enzymatic source of mutation in breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.009

Genomics: Mutator catalogues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.009

An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.009

Evidence for APOBEC3B mutagenesis in multiple human cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.009

APOBEC3B mutagenesis in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.009

APOBEC—a double-edged sword

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.009

Clinical significance of tumor-derived IL-1β and IL-18 in localized renal cell carcinoma: Associations with recurrence and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.009

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.009

High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.009

Population stratification of a common APOBEC gene deletion polymorphism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.009

7 January 2021

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.009

Renal cell carcinoma stage migration in a single European centre over 25 years: effects on 5- and 10-year metastasis-free survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.009

Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.009

Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.009

Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.009

Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.009

Prognostic value of diametrically polarized tumor-associated macrophages in renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.009

Biomarkers in personalised treatment of renal-cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.009

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.05.009

10.1016/J.UROLONC.2015.05.009

7 January 2021

Identifiers

DOI

1 reference

7 October 2017

1 reference